Tools

LEADER 04400cam a2200577 i 4500

001 on1371248835;

003 OCoLC;

005 20240729154349.0;

006 m o d ;

007 cr unu||||||||;

008 230227s2022 ncua obm 000 0 eng d;

035 a| (Sirsi) o1371248835;

035 a| (OCoLC)1371248835;

049 a| EREE;

100 1 a| Talic, Emily Satterwhite,e| author.?| UNAUTHORIZED;

245 10 a| Human RNA methyltransferase METTL16 affects multiple cell processes through differential function of its domains /c| by Emily Satterwhite Talic.;

264 1 a| [Greenville, N.C.] :b| [East Carolina University],c| 2022.;

300 a| 1 online resource (166 pages) :b| illustrations (mostly color).;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

347 a| text fileb| PDFc| 2.664 MB2| rda;

490 1 a| ECU Brody School of Medicine thesis;

538 a| System requirements: Adobe Reader.;

538 a| Mode of access: World Wide Web.;

502 b| Ph.D.c| East Carolina Universityd| 2022.;

500 a| Presented to the faculty of the Department of Biochemistry and Molecular Biology;

500 a| Advisor: Kyle Mansfield;

500 a| Title from .PDF title page (viewed April 30, 2024).;

504 a| Includes bibliographical references.;

520 3 a| ABSTRACT In recent years, disease therapies have been developed to target specific RNA and protein expression changes in the affected cells/tissue. The RNA post-transcriptional modification, methyl-6-adenosine (m6A), has been implicated in a number of disease-states as a driver of aberrant RNA and protein expression. m6A is the reversible methylation of adenosine which is produced by enzymes known as m6A RNA methyltransferases. There are currently two known m6A RNA methyltransferases which methylate messenger RNA in humans: METTL3/14 complex, and METTL16. The METTL3/14 complex has been widely implicated and studied in cancer development and progression, while much of METTL16 has not been investigated. While a few studies have probed the biochemical details of METTL16, cancer studies have shown METTL16 protein expression level changes have been associated with a variety of cancer types. The research in this dissertation project was performed in an effort to determine the RNAs affected by and the cell-wide effects of METTL16's function. Using RNA immunoprecipitation, the studies here show that METTL16 binds a number of RNAs outside the 3 that are currently accepted as RNA targets. It was also discovered that METTL16 is localized to both the nucleus and cytoplasm, suggesting a role in addition to methylation in the cell. Mutation of key residues in METTL16 protein resulted in a large number of changes in RNA and protein expression levels determined with RNA sequencing, real-time PCR, and mass spectrometry proteomics. A majority of these RNAs and proteins are associated with cytoskeletal maintenance, calcium signaling, and cell cycle regulation, all of which have implications in distinct diseases including cancer. Of interest, only some of the METTL16 mutations seemed to affect cell cycle phase occupancy. Given the multiple changes seen among cells containing mutated METTL16, it is plausible that this protein could aid in presentation or progression of associated diseases and could therefore be a justified target for cell therapies.;

650 2 a| Methyltransferases.=| ^A1203294;

650 2 a| RNA Methylation.=| ^A1470204;

650 2 a| Neoplasms.=| ^A917584;

653 a| METTL16;

653 a| RNA;

653 a| m6A;

653 a| cancer;

700 1 a| Mansfield, Kyle,e| degree supervisor.?| UNAUTHORIZED;

710 2 a| East Carolina University.b| Department of Biochemistry and Molecular Biology.?| UNAUTHORIZED;

830 0 a| ECU Brody School of Medicine thesis.=| ^A964744;

856 40 z| Access via ScholarShipu| http://hdl.handle.net/10342/12231;

949 a| Click on web addressw| ASISh| JOYNER101;

949 a| Click on web addressw| ASISh| HSL111;

994 a| C0b| ERE;

096 a| QU 141;

596 a| 1 4;

998 a| 5961407;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5961407-1001l| JNETm| JOYNERr| Ys| Yt| JNE3ETDu| 3/1/2023x| ETDz| JERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5961407-2001l| HSLELECm| HSLr| Ys| Yt| HEETDu| 3/1/2023x| ETDz| HERESOURCE;

Human RNA methyltransferase METTL16 affects multiple cell processes through differential function of its domains / by Emily Satterwhite Talic.

Author/creator	Talic, Emily Satterwhite author.
Other author	Mansfield, Kyle, degree supervisor.
Other author	East Carolina University. Department of Biochemistry and Molecular Biology.
Format	Theses and dissertations
Publication	[Greenville, N.C.] : [East Carolina University], 2022.
Description	1 online resource (166 pages) : illustrations (mostly color).
Supplemental Content	Access via ScholarShip
Subjects	Methyltransferases. RNA Methylation. Neoplasms.

Series	ECU Brody School of Medicine thesis ECU Brody School of Medicine thesis. ^A964744
Summary	ABSTRACT In recent years, disease therapies have been developed to target specific RNA and protein expression changes in the affected cells/tissue. The RNA post-transcriptional modification, methyl-6-adenosine (m6A), has been implicated in a number of disease-states as a driver of aberrant RNA and protein expression. m6A is the reversible methylation of adenosine which is produced by enzymes known as m6A RNA methyltransferases. There are currently two known m6A RNA methyltransferases which methylate messenger RNA in humans: METTL3/14 complex, and METTL16. The METTL3/14 complex has been widely implicated and studied in cancer development and progression, while much of METTL16 has not been investigated. While a few studies have probed the biochemical details of METTL16, cancer studies have shown METTL16 protein expression level changes have been associated with a variety of cancer types. The research in this dissertation project was performed in an effort to determine the RNAs affected by and the cell-wide effects of METTL16's function. Using RNA immunoprecipitation, the studies here show that METTL16 binds a number of RNAs outside the 3 that are currently accepted as RNA targets. It was also discovered that METTL16 is localized to both the nucleus and cytoplasm, suggesting a role in addition to methylation in the cell. Mutation of key residues in METTL16 protein resulted in a large number of changes in RNA and protein expression levels determined with RNA sequencing, real-time PCR, and mass spectrometry proteomics. A majority of these RNAs and proteins are associated with cytoskeletal maintenance, calcium signaling, and cell cycle regulation, all of which have implications in distinct diseases including cancer. Of interest, only some of the METTL16 mutations seemed to affect cell cycle phase occupancy. Given the multiple changes seen among cells containing mutated METTL16, it is plausible that this protein could aid in presentation or progression of associated diseases and could therefore be a justified target for cell therapies.
General note	Presented to the faculty of the Department of Biochemistry and Molecular Biology
General note	Advisor: Kyle Mansfield
General note	Title from .PDF title page (viewed April 30, 2024).
Dissertation note	Ph.D. East Carolina University 2022.
Bibliography note	Includes bibliographical references.
Technical details	System requirements: Adobe Reader.
Technical details	Mode of access: World Wide Web.

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Human RNA methyltransferase METTL16 affects multiple cell processes through differential function of its domains / by Emily Satterwhite Talic.

Click here for more information about this title

Availability